MedTrace Logo

A Naturalistic Controlled Trial of Individual Placement and Control in Bodø

NCT04179877 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77000

Last updated 2019-11-27

No results posted yet for this study

Summary

The investigators aim to test the effectiveness of Individual Placement and Support (IPS) on

1. employment,
2. welfare dependency, and
3. public-sector health care utilization.

This is a naturalistic controlled trial, where one municipality (Bodø in Norway) with about 50000 inhabitants get access to IPS services in public sector mental health services during the period 2013-2016. The target group for the intervention is patients with severe mental illness (SMI) in the age group 18-40 at time of treatment. Patients already receiving lifelong disability benefits will be excluded.

The control group will be an average of 10 municipalities in Norway without IPS services.

Data for outcomes will be based on public registries available for research.

Conditions

  • Severe Mental Disorder

Interventions

BEHAVIORAL

IPS

Occupational rehabilitation and support Integrated with clinical treatment

Sponsors & Collaborators

  • Nordlandssykehuset HF

    collaborator OTHER

  • University of Tromso

    collaborator OTHER

  • London School of Economics and Political Science

    collaborator OTHER

  • University of Melbourne

    collaborator OTHER

  • St George's Healthcare NHS Trust

    collaborator OTHER

  • The University of New South Wales

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Arnstein Mykletun, Prof PsyD · Norwegian IPH

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2016-12-31
Completion
2022-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04179877 on ClinicalTrials.gov